Entity Details

Primary name AP4M1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionO00189
EntryNameAP4M1_HUMAN
FullNameAP-4 complex subunit mu-1
TaxID9606
Evidenceevidence at protein level
Length453
SequenceStatuscomplete
DateCreated2001-04-27
DateModified2021-06-02

Ontological Relatives

GenesAP4M1

GO terms

Show/Hide Table
GOName
GO:0005769 early endosome
GO:0005802 trans-Golgi network
GO:0005829 cytosol
GO:0006605 protein targeting
GO:0006622 protein targeting to lysosome
GO:0006886 intracellular protein transport
GO:0006892 post-Golgi vesicle-mediated transport
GO:0006895 Golgi to endosome transport
GO:0008104 protein localization
GO:0016192 vesicle-mediated transport
GO:0019904 protein domain specific binding
GO:0030124 AP-4 adaptor complex
GO:0030131 clathrin adaptor complex
GO:0031410 cytoplasmic vesicle
GO:0031904 endosome lumen
GO:0032588 trans-Golgi network membrane
GO:0043231 intracellular membrane-bounded organelle
GO:0070062 extracellular exosome
GO:0090160 Golgi to lysosome transport
GO:1903361 protein localization to basolateral plasma membrane

Subcellular Location

Show/Hide Table
Subcellular Location
Early endosome
Golgi apparatus

Domains

Show/Hide Table
DomainNameCategoryType
IPR001392 Clathrin adaptor, mu subunitFamilyFamily
IPR011012 Longin-like domain superfamilyFamilyHomologous superfamily
IPR018240 Clathrin adaptor, mu subunit, conserved siteSiteConserved site
IPR022775 AP complex, mu/sigma subunitDomainDomain
IPR028565 Mu homology domainDomainDomain
IPR036168 AP-2 complex subunit mu, C-terminal superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
612936 OMIMSpastic paraplegia 50, autosomal recessive (SPG50)A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG50 affected individuals present postnatally with early infantile hypotonia, delayed psychomotor development, strabismus, lack of independent walking and severe mental retardation. They develop progressive spasticity of all limbs with generalized hypertonia, hyperreflexia, and extensor plantar responses by the end of the first year of life. Speech is absent or limited. Pseudobulbar signs, such as drooling, stereotypic laughter, and exaggerated jaw jerk, are part of the clinical picture. The disease is caused by variants affecting the gene represented in this entry.